ANI PHARMACEUTICALS INC. - COMMON STOCK

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes

13 8月 2024 16:05:27 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

07 8月 2024 21:44:18 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

07 8月 2024 07:00:55 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

06 8月 2024 06:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET

31 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

15 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

02 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

25 6月 2024 07:00:02 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

24 6月 2024 06:50:44 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference

29 5月 2024 16:30:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension

20 5月 2024 06:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance

10 5月 2024 06:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

01 5月 2024 16:30:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET

18 4月 2024 16:05:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension

09 4月 2024 06:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis

04 4月 2024 06:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium

03 4月 2024 06:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP

27 3月 2024 06:50:00 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance

29 2月 2024 06:50:01 条件 Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference

20 2月 2024 06:50:00 条件 Nasdaq GlobeNewswire